173 related articles for article (PubMed ID: 16443735)
1. Caspase activity is downregulated in choriocarcinoma: a cDNA array differential expression study.
Fong PY; Xue WC; Ngan HY; Chiu PM; Chan KY; Tsao SW; Cheung AN
J Clin Pathol; 2006 Feb; 59(2):179-83. PubMed ID: 16443735
[TBL] [Abstract][Full Text] [Related]
2. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
Cui JQ; Shi YF; Zhou HJ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
5. The changes of gene expression profiles in hydatidiform mole and choriocarcinoma with hyperplasia of trophoblasts.
Cui JQ; Shi YF; Zhou HJ; Li JQ
Int J Gynecol Cancer; 2004; 14(5):984-97. PubMed ID: 15361213
[TBL] [Abstract][Full Text] [Related]
6. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
[TBL] [Abstract][Full Text] [Related]
7. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases.
Xue WC; Feng HC; Tsao SW; Chan KY; Ngan HY; Chiu PM; Maccalman CD; Cheung AN
Int J Gynecol Cancer; 2003; 13(6):879-88. PubMed ID: 14675328
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW
Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
Wong SY; Ngan HY; Chan CC; Cheung AN
Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in gestational trophoblastic disease.
Cheung AN; Zhang DK; Liu Y; Ngan HY; Shen DH; Tsao SW
J Clin Pathol; 1999 Aug; 52(8):588-92. PubMed ID: 10645228
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody.
Chiu PM; Ngan YS; Khoo US; Cheung AN
Histopathology; 2001 Mar; 38(3):243-9. PubMed ID: 11260306
[TBL] [Abstract][Full Text] [Related]
13. Detection of placental growth hormone variant and chorionic somatomammotropin ribonucleic acid expression in human trophoblastic neoplasms by reverse transcriptase-polymerase chain reaction.
Lytras A; Bock ME; Dodd JG; Cattini PA
Endocrinology; 1994 Jun; 134(6):2461-7. PubMed ID: 7515000
[TBL] [Abstract][Full Text] [Related]
14. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases.
Fulop V; Colitti CV; Genest D; Berkowitz RS; Yiu GK; Ng SW; Szepesi J; Mok SC
Oncogene; 1998 Jul; 17(4):419-24. PubMed ID: 9696034
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.
Siu MK; Wong ES; Chan HY; Ngan HY; Chan KY; Cheung AN
Am J Pathol; 2008 Oct; 173(4):1165-72. PubMed ID: 18772339
[TBL] [Abstract][Full Text] [Related]
16. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
Lei ZM; Rao CV; Ackerman DM; Day TG
J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
18. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
19. Macrophage colony-stimulating factor induces the growth and differentiation of normal pregnancy human cytotrophoblast cells and hydatidiform moles but does not induce the growth and differentiation of choriocarcinoma cells.
Saito S; Ibaraki T; Enomoto M; Ichijo M; Motoyoshi K
Jpn J Cancer Res; 1994 Mar; 85(3):245-52. PubMed ID: 8188522
[TBL] [Abstract][Full Text] [Related]
20. Activated Stat3 expression in gestational trophoblastic disease: correlation with clinicopathological parameters and apoptotic indices.
Chan HY; Siu MK; Zhang HJ; Wong ES; Ngan HY; Chan KY; Cheung AN
Histopathology; 2008 Aug; 53(2):139-46. PubMed ID: 18752497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
